Suspended
Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese.
What is being tested
lidocaine
+ placebo
Other
Who is being recruted
Signs and Symptoms+1
+ Signs and Symptoms, Digestive
+ Pathological Conditions, Signs and Symptoms
Over 18 Years
+4 Eligibility Criteria
How is the trial designed
Placebo-Controlled
Interventional
Study Start: January 2013
Summary
Principal SponsorRoyal Victoria Hospital, Canada
Study ContactAlbert Moore, mdMore contacts
Last updated: February 15, 2013Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 2013
Actual date on which the first participant was enrolled.The investigators wish to determine if application of 2% lidocaine soaked gauze to the peritonsillar pillars will decrease the amount of gagging caused by awake videolaryngocope assisted tracheal intubation in the morbidly obese.
Principal SponsorRoyal Victoria Hospital, Canada
Study ContactAlbert Moore, mdMore contacts
Last updated: February 15, 2013Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
24 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Signs and SymptomsSigns and Symptoms, DigestivePathological Conditions, Signs and SymptomsGagging
Criteria
1 inclusion criteria required to participate
morbid obese patients scheduled for bariatric surgery, with a planned awake intubation
3 exclusion criteria prevent from participating
allergies to any study drugs
any patient with an American society of anesthesiologists score of 4 or more
inability to communicate in English or french
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalPatients in this arm will have gauze soaked with lidocaine applied to the peritonsillar pillars.
Group II
PlaceboApplication of saline to the glossopharyngeal nerve.
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center